Vienna
Austria
48
2024-10-24
The entities that hold a legal rights for patent applications filed by inventor Dockal Michael:
Michael Dockal from Vienna, AT has applied for patents for these inventions. The list has both pending applications and granted patents:
SELECTIVE MEASUREMENT OF HUMAN FACTOR VIII
#2 | 2020-07-09NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES
#3 | 2019-12-19NON-ANTICOAGULANT SULFATED OR SULFONATED SYNTHETIC POLYMERS
#4 | 2019-12-12NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES
#5 | 2019-08-01Compositions of human prothrombin and activated factor X for improving hemostasis in the treatment of bleeding disorders
#6 | 2019-07-25Biologically active peptides
#7 | 2019-05-09TFPI inhibitors and methods of use
#8 | 2019-05-02NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES
#9 | 2018-09-13NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES
#10 | 2018-06-07TFPI inhibitors and methods of use
#11 | 2018-04-19METHOD FOR PICKING A COLONY OF CELLS
#12 | 2018-03-15TFPI inhibitors and methods of use
#13 | 2017-12-21NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES
#14 | 2017-10-05NON-ANTICOAGULANT SULFATED OR SULFONATED SYNTHETIC POLYMERS
#15 | 2017-06-22TFPI inhibitors and methods of use
#16 | 2017-06-22Biologically active peptides
#17 | 2017-06-08TFPI inhibitors and methods of use
#18 | 2017-06-01METHODS FOR TREATING BLEEDING DISORDERS USING A PLATELET SUBPOPULATION
#19 | 2017-02-09Peptides and methods of use
#20 | 2016-04-28METHODS FOR TREATING BLEEDING DISORDERS USING A PLATELET SUBPOPULATION
#21 | 2016-03-03Biologically active peptides
#22 | 2016-02-18Production of fully processed and functional factor X in a furin-secreting mammalian expression system
#23 | 2016-02-18Factor X activation
#24 | 2015-09-17COMPOSITIONS OF HUMAN PROTHROMBIN AND ACTIVATED FACTOR X FOR IMPROVING HEMOSTASIS IN THE TREATMENT OF BLEEDING DISORDERS
#25 | 2015-09-03Peptides and methods of use
#26 | 2015-08-20TFPI inhibitors and methods of use
#27 | 2015-02-05Biologically active peptides
#28 | 2014-10-02Methods for treating bleeding disorders using a platelet subpopulation
#29 | 2014-02-20Methods and systems for screening compositions comprising non-anticoagulant sulfated polysaccharides
#30 | 2014-02-20Methods for Treating Bleeding Disorders
#31 | 2013-11-14Methods and compositions for treating bleeding disorders
#32 | 2013-10-17TFPI inhibitors and methods of use
#33 | 2013-10-10APTAMERS TO TISSUE FACTOR PATHWAY INHIBITOR AND THEIR USE AS BLEEDING DISORDER THERAPEUTICS
#34 | 2013-10-03TFPI inhibitors and methods of use
#35 | 2013-09-26TFPI inhibitors and methods of use
#36 | 2013-08-15NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES
#37 | 2013-08-08NON-ANTICOAGULANT SULFATED OR SULFONATED SYNTHETIC POLYMERS
#38 | 2012-03-29Procoagulant peptides
#39 | 2012-02-02TFPI inhibitors and methods of use
#40 | 2011-10-06Methods and compositions for treating bleeding disorders
#41 | 2011-08-25FVIII-independent FIX-mutant proteins for hemophilia a treatment
#42 | 2011-07-14Methods and compositions for treating bleeding disorders
#43 | 2011-05-12Method for identifying a non-anticoagulant sulfated polysaccharide which enhances blood coagulation dependence on FXI
#44 | 2010-07-08TFPI inhibitors and methods of use
#45 | 2010-07-01Preparations based on fibrinogen and sulfated polysaccharides
#46 | 2010-01-28Procoagulant peptides
#47 | 2008-09-04FIX-Mutant Proteins for Hemophilia B Treatment
#48 | 2008-09-04FVIII-independent FIX-mutant proteins for hemophilia A treatment
376221 ⎘